Replies to post #24697 on RespireRx Pharmaceuticals Inc (RSPI)

[neuroinv]

I believe the SA trial is planned to enroll 20 patients, though they didn't know how many would have to go through the first two screening nights in order to get 20 who meet criteria.

As to the questions raised by DavidAl etc about whether some event, dire or otherwise, is imminent--if there was an imminent event, they wouldn't have downsized.

NeuroInvestment